We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Qiagen Warned for Incorrect Marketing of ASRs
Qiagen Warned for Incorrect Marketing of ASRs
October 27, 2006
Qiagen inappropriately marketed several of its products as analyte specific reagents (ASRs) and must apply for new FDA approvals, the agency said in a recent warning letter.